Cargando…

Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection

PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Wei-wei, Wang, Qian-qiu, Liu, Wei-da, Shen, Jian-ping, Wang, Hong-sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733875/
https://www.ncbi.nlm.nih.gov/pubmed/23930073
http://dx.doi.org/10.2147/DDDT.S45197
_version_ 1782279422536056832
author Tian, Wei-wei
Wang, Qian-qiu
Liu, Wei-da
Shen, Jian-ping
Wang, Hong-sheng
author_facet Tian, Wei-wei
Wang, Qian-qiu
Liu, Wei-da
Shen, Jian-ping
Wang, Hong-sheng
author_sort Tian, Wei-wei
collection PubMed
description PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investigated in an immune cell-bacillus coculture system in vitro. As a potential novel immunotherapy, M. marinum was studied and compared with two other bacilli, Bacillus Calmette-Guérin (BCG) and live attenuated M. tuberculosis. We examined the changes in both the bacilli and immune cells, especially the time course of the viability of mycobacteria in the coculture system and host immune responses including multinuclear giant cell formation by Wright-Giemsa modified staining, macrophage polarization by cell surface antigen expression, and cytokines/chemokine production by both mRNA expression and protein secretion. RESULTS: The M. marinum stimulated coculture group showed more expression of CD209, CD68, CD80, and CD86 than the BCG and M. tuberculosis (an attenuated strain, H37Ra) groups, although the differences were not statistically significant. Moreover, the M. marinum group expressed more interleukin (IL)-1B and IL-12p40 on day 3 (IL-1B: P = 0.003 and 0.004, respectively; IL-12p40: P = 0.001 and 0.011, respectively), a higher level of CXCL10 on day 1 (P = 0.006 and 0.026, respectively), and higher levels of chemokine (C-X-C motif) ligand (CXCL) 8 and chemokine (C motif) ligand (XCL) 1 on day 3 (CXCL8: P = 0.012 and 0.014, respectively; XCL1: P = 0.000 and 0.000, respectively). The M. marinum stimulated coculture group also secreted more tumor necrosis factor (TNF)-α, IL-1β, and IL-10 on day 1 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.000, respectively; IL-10: P = 0.002 and 0.019, respectively) and day 3 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.001, respectively; IL-10: P = 0.000 and 0.000, respectively). In addition, the colony-forming units (an index of viability) of M. marinum in the M. marinum stimulated coculture group was significantly less than that of BCG and H37Ra in their corresponding bacillus stimulated groups (P = 0.037 and 0.013, respectively). CONCLUSION: Our results indicated that M. marinum could be a potentially safe and effective immunotherapy.
format Online
Article
Text
id pubmed-3733875
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37338752013-08-08 Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection Tian, Wei-wei Wang, Qian-qiu Liu, Wei-da Shen, Jian-ping Wang, Hong-sheng Drug Des Devel Ther Original Research PURPOSE: The aim of the present study was to investigate the immune response induced by Mycobacterium marinum infection in vitro and the potential of M. marinum as an immunotherapy for M. tuberculosis infection. METHODS: The potential human immune response to certain bacillus infections was investigated in an immune cell-bacillus coculture system in vitro. As a potential novel immunotherapy, M. marinum was studied and compared with two other bacilli, Bacillus Calmette-Guérin (BCG) and live attenuated M. tuberculosis. We examined the changes in both the bacilli and immune cells, especially the time course of the viability of mycobacteria in the coculture system and host immune responses including multinuclear giant cell formation by Wright-Giemsa modified staining, macrophage polarization by cell surface antigen expression, and cytokines/chemokine production by both mRNA expression and protein secretion. RESULTS: The M. marinum stimulated coculture group showed more expression of CD209, CD68, CD80, and CD86 than the BCG and M. tuberculosis (an attenuated strain, H37Ra) groups, although the differences were not statistically significant. Moreover, the M. marinum group expressed more interleukin (IL)-1B and IL-12p40 on day 3 (IL-1B: P = 0.003 and 0.004, respectively; IL-12p40: P = 0.001 and 0.011, respectively), a higher level of CXCL10 on day 1 (P = 0.006 and 0.026, respectively), and higher levels of chemokine (C-X-C motif) ligand (CXCL) 8 and chemokine (C motif) ligand (XCL) 1 on day 3 (CXCL8: P = 0.012 and 0.014, respectively; XCL1: P = 0.000 and 0.000, respectively). The M. marinum stimulated coculture group also secreted more tumor necrosis factor (TNF)-α, IL-1β, and IL-10 on day 1 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.000, respectively; IL-10: P = 0.002 and 0.019, respectively) and day 3 (TNF-α: P = 0.000 and 0.000, respectively; IL-1β: P = 0.000 and 0.001, respectively; IL-10: P = 0.000 and 0.000, respectively). In addition, the colony-forming units (an index of viability) of M. marinum in the M. marinum stimulated coculture group was significantly less than that of BCG and H37Ra in their corresponding bacillus stimulated groups (P = 0.037 and 0.013, respectively). CONCLUSION: Our results indicated that M. marinum could be a potentially safe and effective immunotherapy. Dove Medical Press 2013-07-29 /pmc/articles/PMC3733875/ /pubmed/23930073 http://dx.doi.org/10.2147/DDDT.S45197 Text en © 2013 Tian et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Tian, Wei-wei
Wang, Qian-qiu
Liu, Wei-da
Shen, Jian-ping
Wang, Hong-sheng
Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title_full Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title_fullStr Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title_full_unstemmed Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title_short Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
title_sort mycobacterium marinum: a potential immunotherapy for mycobacterium tuberculosis infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733875/
https://www.ncbi.nlm.nih.gov/pubmed/23930073
http://dx.doi.org/10.2147/DDDT.S45197
work_keys_str_mv AT tianweiwei mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection
AT wangqianqiu mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection
AT liuweida mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection
AT shenjianping mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection
AT wanghongsheng mycobacteriummarinumapotentialimmunotherapyformycobacteriumtuberculosisinfection